Cyclerion Therapeutics (CYCN)
(Delayed Data from NSDQ)
$2.73 USD
-0.52 (-16.00%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $2.61 -0.12 (-4.40%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Cyclerion Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CYCN 2.73 -0.52(-16.00%)
Will CYCN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CYCN based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for CYCN
12 Health Care Stocks Moving In Thursday's Intraday Session
CYCN forms Pocket Pivot on September 25
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Cyclerion Therapeutics, Inc. (CYCN) Discusses On Pioneering A New Era In Neuropsychiatric Therapies Call (Transcript)
Cyclerion Therapeutics, Inc. (CYCN) Discusses on Pioneering a New Era in Neuropsychiatric Therapies